BILLERICA, Mass., Jan 12, 2011 (BUSINESS WIRE) -- Bruker announces an order valued at over $7.5 million from the University of Minnesota for its new Nuclear Magnetic Resonance (NMR) laboratory, including ultra-high fieldAvance(TM) III 900andAvance(TM) III 850NMR spectrometers. The systems will be installed in the newly constructed and greatly expanded NMR Facility at the University of Minnesota.
This purchase will form the core of the systems in the NMR Facility for use in a wide range of research at theUniversity of Minnesota, including structure determination of proteins and nucleic acids related to cancer, heart failure, infectious disease, muscular dystrophy, aging, neurodegeneration, and metabolomics.
TheAvance(TM) III 900system is based on Bruker's successful 900 MHz (21.2 Tesla) actively-shieldedUS2magnet, one of the highest magnetic fields for NMR applications. The 900 MHzUS2magnet combines Bruker's proven proprietaryUltraShield (TM)active-shielding andUltraStabilized(TM)sub-cooling technologies. The result is the most reliable 900 MHz magnet for NMR applications. TheAvance(TM) III 850spectrometer is based on Bruker's new 850 MHz提升(TM)magnet that combines the key advantages of Bruker's well-establishedUltraShield (TM)Plusmagnets with advanced superconductor technology resulting in significant reductions in magnetic stray fields and in the size of the cryostat. With over 170 ultra-high field installations worldwide, Bruker has an unmatched track record in NMR magnet technology.
"This purchase demonstrates the University of Minnesota's commitment to excellence in research," said Prof. David Thomas, NMR Facility Director. "Specifically, these new Bruker instruments will enhance this University's position as a world leader in the advancement of biomedical research using magnetic resonance."
About Bruker Corporation
Bruker Corporation (NASDAQ: BRKR) is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analysis. For more information, please visitwww.fatactor.com.
Photos/Multimedia Gallery Available:www.businesswire.com/cgi-bin/mmg.cgi?eid=6569131&lang=en
SOURCE: Bruker Corporation
Bruker BioSpin
Dr. Thorsten Thiel, +49 (0)721 - 5161 - 6517
C公司的营销总监ommunications
thorsten.thiel@bruker.com